13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
The PlexusDx Precision Peptide Genetic Test analyzes 49 peptides and 150+ genetic insights across 14 metabolic pathways, including GLP1R sensitivity and appetite-control genes
We calculated the mean fluorescent intensity (MFI) using ImageJ software as described in Methods
We are paying close attention to misleading claims being made by telehealth and pharma companies across all media platformsand taking swift action, Makary said